191 related articles for article (PubMed ID: 25868960)
41. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
Tomilina NA; Gendlin GE; Zhidkova DA; Tronina OA; Fedorova ND
Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
[TBL] [Abstract][Full Text] [Related]
42. Persistent hypertension in Thai children: etiologies and outcome.
Sumboonnanonda A; Chongcharoensuk C; Supavekin S; Pattaragarn A
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S28-32. PubMed ID: 17044451
[TBL] [Abstract][Full Text] [Related]
43. Management of hypertensive crises.
Feldstein C
Am J Ther; 2007; 14(2):135-9. PubMed ID: 17414580
[TBL] [Abstract][Full Text] [Related]
44. Regression of left ventricular hypertrophy in hypertension--does it reduce cardiovascular risk?
Braz Nogueira J
Rev Port Cardiol; 2005; 24(7-8):1007-13. PubMed ID: 16240686
[TBL] [Abstract][Full Text] [Related]
45. Relationship between different blood pressure measurements and left ventricular mass by cardiac magnetic resonance imaging in end-stage renal disease.
Merchant A; Wald R; Goldstein MB; Yuen D; Kirpalani A; Dacouris N; Ray JG; Kiaii M; Leipsic J; Kotha V; Deva D; Yan AT
J Am Soc Hypertens; 2015 Apr; 9(4):275-84. PubMed ID: 25753299
[TBL] [Abstract][Full Text] [Related]
46. Takayasu arteritis, malignant hypertension and severe left ventricular hypertrophy.
Vargas-Hitos JA; Jiménez-Jáimez J; Molina Navarro E; Salmerón Ruiz A; López Milena G; Jiménez-Alonso J
Int J Rheum Dis; 2019 May; 22(5):951-955. PubMed ID: 30861323
[No Abstract] [Full Text] [Related]
47. Hypertensive emergencies.
Moore MA
Am Fam Physician; 1980 Mar; 21(3):141-6. PubMed ID: 7355684
[TBL] [Abstract][Full Text] [Related]
48. Bilateral nephrectomy and renal homotransplantation for malignant nephrosclerosis.
Payne JE; Silcott GR; Mendez R; Barbour BH; Berne TV
Arch Surg; 1973 Jul; 107(1):17-20. PubMed ID: 4576897
[No Abstract] [Full Text] [Related]
49. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
50. Clinical and pathological evaluation of hypertensive emergency-related nephropathy.
Nonaka K; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Sawa N; Takaichi K; Kuroda Y; Oohashi K
Intern Med; 2013; 52(1):45-53. PubMed ID: 23291673
[TBL] [Abstract][Full Text] [Related]
51. Eleven-year follow-up of a patient with malignant hypertension secondary to pyelonephritis and renal insufficiency.
Mawar T; Rojo-Ortega JM; Genest J
Can Med Assoc J; 1968 Jul; 99(4):184-6. PubMed ID: 5673225
[No Abstract] [Full Text] [Related]
52. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
Dahlöf B
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
[TBL] [Abstract][Full Text] [Related]
53. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
54. Hydrocephalus associated with malignant hypertension and renal failure.
Washio M; Oh Y; Maehara F; Takeno Y; Miishima C; Fujimi S
Nephron; 1990; 56(2):222-3. PubMed ID: 2243583
[No Abstract] [Full Text] [Related]
55. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
[TBL] [Abstract][Full Text] [Related]
56. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
Gradman AH; Alfayoumi F
Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
[TBL] [Abstract][Full Text] [Related]
57. Effect of intravitreal bevacizumab (Avastin(®)) therapy in malignant hypertensive retinopathy: a report of two cases.
Kim EY; Lew HM; Song JH
J Ocul Pharmacol Ther; 2012 Jun; 28(3):318-22. PubMed ID: 22149905
[TBL] [Abstract][Full Text] [Related]
58. Cardiac consequences of renal transplantation changes in left ventricular morphology.
Alvares S; Mota C; Soares L; Henriques C; Pereira E; Sarmento AM; Lima CA
Rev Port Cardiol; 1998 Feb; 17(2):145-52. PubMed ID: 9587210
[TBL] [Abstract][Full Text] [Related]
59. Hypertensive crisis with 2 target organ impairment induced by glycyrrhizin: A case report.
Li J; Fan X; Wang Q
Medicine (Baltimore); 2018 Mar; 97(11):e0073. PubMed ID: 29538199
[TBL] [Abstract][Full Text] [Related]
60. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
